RYTM — RHYTHM PHARMACEUTICALS INC

Ownership history in EntryPoint Capital, LLC  ·  2 quarters on record

This page tracks every 13F SEC filing in which EntryPoint Capital, LLC reported a position in RHYTHM PHARMACEUTICALS INC (RYTM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.08% (2025 Q3)
Avg. % of fund
0.05%
First filed
2023 Q4
Last filed
2025 Q3
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 1,993 +1,676 +528.7% 0.08% $201K $100.99
2023 Q4 INITIATED 317 — — 0.01% $15K —
% of Fund (quarterly)    RYTM price (monthly, adj. close)

Other funds also holding RYTM

As of 2025 Q4 — sorted by position size

Checkpoint Capital L.P. 33.18% NEA Management Company, LLC 3Y 7Y 15.88% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 7.31% PERCEPTIVE ADVISORS LLC 3Y 7Y 4.86% Nan Fung Group Holdings Ltd 3Y 4.71% Opaleye Management Inc. 3Y 7Y 4.66% Sio Capital Management, LLC 3Y 7Y 4.47% Rock Springs Capital Management LP 3Y 7Y 3.81% BAKER BROS. ADVISORS LP 3Y 7Y 3.51% Integral Health Asset Management, LLC 3Y 2.52%
← Back to EntryPoint Capital, LLC Holdings